Lysergic Acid Diethylamide (LSD)

Jump to:

Page 4
(2015-2017)

Schindler et al. (2015). Indoleamine hallucinogens in cluster headache: Results of the Clusterbusters medication use survey. Journal of Psychoactive Drugs.

Schmid et al. (2015). Acute effects of lysergic acid diethylamide in healthy subjects. Biological Psychiatry.

Torjesen (2015). Crowdfunding sought for study that will provide first images of human brain on LSD. BMJ.

Brandt et al. (2016). Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Drug Testing and Analysis.

Carhart-Harris et al. (2016). The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychological Medicine.

Carhart-Harris et al. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences of the United States of America.

Das et al. (2016). Lysergic acid diethylamide: a drug of 'use'? Therapeutic Advances in Psychopharmacology.

De Gregorio et al. (2016). d-lysergic acid diethylamide (LSD) as a model of psychosis: mechanism of action and pharmacology. International Journal of Molecular Sciences.

De Gregorio et al. (2016). The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors. Pharmacological Research.

Dolder et al. (2016). LSD acutely impairs fear recognition and enhances emotional empathy and sociality. Neuropsychopharmacology.

Dolder et al. (2016). Pharmacokinetics and concentration-effect relationship of oral LSD in humans. International Journal of Neuropsychopharmacology.

Dos Santos et al. (2016). Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology.

Family et al. (2016). Semantic activation in LSD: Evidence from picture naming. Language, Cognition and Neuroscience.

Kaelen et al. (2016). LSD modulates music-induced imagery via changes in parahippocampal connectivity. European Neuropsychopharmacology.

Kyzar, Stewart & Kalueff (2016). Effects of LSD on grooming behavior in serotonin transporter heterozygous ( Sert+/−) mice. Behavioural Brain Research.

Larsen (2016). Neurotoxicity and LSD treatment: a follow-up study of 151 patients in Denmark. History of Psychiatry.

Lebedev et al. (2016). LSD-induced entropic brain activity predicts subsequent personality change. Human Brain Mapping.

Mucke (2016). From psychiatry to flower power and back again: The amazing story of lysergic acid diethylamide. Assay and Drug Development Technologies.

Oram (2016). Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration.

Roseman et al. (2016). LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion. Human Brain Mapping.

Speth et al. (2016). Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide. Journal of Psychopharmacology.

Strajhar et al. (2016). Acute effects of lysergic acid diethylamide on circulating steroid levels in healthy subjects. Journal of Neuroendocrinology.

Tagliazucchi et al. (2016). Increased global functional connectivity correlates with LSD-induced ego dissolution. Current Biology.

Terhune et al. (2016). A placebo-controlled investigation of synaesthesia-like experiences under LSD. Neuropsychologia.

Atasoy et al. (2017). Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD. Scientific Reports.

Barrett et al. (2017). Serotonin 2A receptor signaling underlies lsd-induced alteration of the neural response to dynamic changes in music. Cerebral Cortex.

Coney et al. (2017). Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile. Human Psychopharmacology: Clinical and Experimental.

Dolder et al. (2017). Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects. Clinical Pharmacokinetics; Auckland.

Dolder et al. (2017). A single dose of LSD does not alter gene expression of the serotonin 2A receptor gene (HTR2A) or early growth response genes (EGR1-3) in healthy subjects. Frontiers in Pharmacology.

Erritzoe, Nutt & Carhartt-Harris (2017). Concerns regarding conclusions made about LSD-treatments. History of Psychiatry.

Gawinecka et al. (2017). Pitfalls of LSD screening assays: comparison of KIMS and CEDIA immunoassays with LC-MS. Clinical Chemistry and Laboratory Medicine.

Gomo et al. (2017). Temporal and spatial distribution of lumpy skin disease (LSD) outbreaks in Mashonaland West Province of Zimbabwe from 2000 to 2013. Tropical Animal Health and Production.

Halberstadt (2017). Hallucinogenic drugs: a new study answers old questions about LSD. Current Biology.

Juszczak (2017). Disrupted integration of sensory stimuli with information about the movement of the body as a mechanism explaining LSD-induced experience. Medical Hyptheses.

Kapócs et al. (2017). Possible role of biochemiluminescent photons for lysergic acid diethylamide(LSD)-induced phosphenes and visual hallucinations. Reviews in the Neurosciences.

Kraehenmann et al. (2017). Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation. Psychopharmacology.

Kraehenmann et al. (2017). LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation. Frontiers in Pharmacology.

Larsen (2017). LSD treatment in Scandinavia: Emphasizing indications and short-term treatment outcomes of 151 patients in Denmark. Nordic Journal of Psychiatry.

Lev-Ran et al. (2017). Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use. The American Journal on Addictions.

Liechti (2017). Modern clinical research on LSD. Neuropsychopharmacology.

Liechti, Dolder & Schmid (2017). Alterations of consciousness and mystical-type experiences after acute LSD in humans. Psychopharmacology.

Mardal et al. (2017). Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD). Forensic Science International.

Mueller et al. (2017). Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects. Translational Psychiatry.

Müller et al. (2017). Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations. Acta Psychiatrica Scandinavica.

Preller et al. (2017). The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation. Current Biology.

Remy et al. (2017). Anxiety and depression symptoms in Brazilian sexual minority ecstasy and LSD users. Trends in Psychiatry and Psychotherapy.

Richeval et al. (2017). LSD Detection and Interpretation in Hair. Current Pharmaceutical Design.

Ross (2017). LSD experiments by the United States Army. History of Psychiatry.

Schmidt et al. (2017). Acute LSD effects on response inhibition neural networks. Psychological Medicine.

Steuer et al. (2017). Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans. Drug Testing and Analysis.

Timmermann et al. (2017). LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm. Neuropharmacology.

Wacker et al. (2017). Crystal structure of an LSD-bound human serotonin receptor. Cell.